Lynn M. Roy, PhD

Bio

Lynn Roy has experience in both industrial and academic research. In graduate school, he worked in the field of reproductive endocrinology. His dissertation examined cross-talk between cAMP/PKA and GSK3 beta / beta-catenin signaling in corpus luteum progesterone synthesis. After obtaining his doctorate, Lynn continued his research career at Novartis Pharma in Basel, Switzerland where he changed his focus and worked in the bone group researching potential treatments for osteoporosis. Upon return to the U.S., Lynn joined the laboratories of Dr. Karen Cowden Dahl and Dr. Richard Dahl at the Indiana University School of Medicine-South Bend as a postdoctoral fellow. There he worked on two different projects 1) examining the regulation of blood development by a particular microRNA, miR24 and 2) studying the role of ARID3B in ovarian cancer progression, metastasis, and relapse.

While Lynn thoroughly enjoyed bench work, he decided to attend the University of Notre Dame’s Master of Science in Patent Law program. While in the Patent Law program, he gained experience with the patenting process from disclosure to the issued patent. One of Lynn's projects was filed with the USPTO after revisions. Lynn also worked in the Intellectual Property and Entrepreneurship Clinic helping local inventors protect their inventions.

Currently, Lynn lectures at Indiana University School of Medicine-South Bend. He is a site course director for the Fundamentals of Health and Disease course and gives most of the pharmacology lectures to both the first and second year students. In addition to pharmacology, he also lectures on lipid and ethanol metabolism in the biochemistry section. Lynn also acts as a facilitator for team based learning, problem based learning, and small group exercises mainly with the first year medical students and occasionally for the case based learning with the second year students.